Cancer Communications (Oct 2021)

Clinical outcomes of second‐line treatment following first‐line VEGFR‐TKI failure in patients with metastatic renal cell carcinoma: a comparison of axitinib alone and axitinib plus anti‐PD‐1 antibody

  • Jiwei Huang,
  • Yueming Wang,
  • Haoran Zhang,
  • Xiaoyi Hu,
  • Ping Wang,
  • Wen Cai,
  • Yichu Yuan,
  • Hao Zeng,
  • Jin Zhang,
  • Wen Kong,
  • Yiran Huang,
  • Shuo Wang,
  • Jianming Guo,
  • Qiang Wei,
  • Wei Xue

DOI
https://doi.org/10.1002/cac2.12206
Journal volume & issue
Vol. 41, no. 10
pp. 1071 – 1074

Abstract

Read online

No abstracts available.